Michigan Biosciences Industry Association Logo

Advocacy

Stay informed on advocacy efforts driving growth and innovation in the bio-industry. This category features updates, initiatives, and insights focused on promoting policies and actions that support our thriving community.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates BioConnections® Jobs Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
MichBio on Capitol Hill: Advancing Michigan's Voice in the National Biotech Policy Debate
Posted In: Federal Advocacy,
Date posted Apr 19

MichBio joined leaders from across the country in Washington, D.C. for the 2026 Council of StateBioscience Associations (CSBA) Fly-In, bringing...

Read Post
Biodefense Hearing in Ann Arbor: Key Takeaways
Posted In: Advocacy,
Date posted Apr 19

Michigan’s role in the national biosciences economy - and its importance to U.S. biodefense - took center stage on April 10 as the...

Read Post
SBIR/STTR Reauthorization Awaits Trump's Signature
Posted In: Federal Advocacy,
Date posted Apr 6

Congress passed long-awaited legislation to reauthorize the SBIR and STTR programs, sending the bill to President Trump on April 1, 2026, for...

Read Post
Pharmaceutical Tariffs Raise Concerns for Innovation Economy and Emerging Biotech
Posted In: Federal Advocacy,
Date posted Apr 6

The White House this past week announced a sweeping new tariff policy targeting imported patented pharmaceutical products, positioning the move as...

Read Post
FY27 Budget Proposal Signals Continued Pressure on NIH, NSF, FDA — Raising Stakes for US Innovation
Posted In: Federal Advocacy,
Date posted Apr 6

The Trump Administration’s FY2027 budget proposal underscores a significant shift in federal priorities—pairing a record $1.5 trillion...

Read Post
SBIR/STTR Reauthorization Advances to President's Desk
Posted In: Federal Advocacy,
Date posted Mar 20

The future of the SBIR/STTR programs has been a critical issue for the life sciences innovation ecosystem, as highlighted in prior biolink...

Read Post
FDA Signals Shift Toward Human-Based Drug Testing as NIH Commits to $150M to Alternatives
Posted In: Federal Advocacy,
Date posted Mar 20

The U.S. drug development landscape is entering a pivotal transition, as federal regulators and research funders accelerate efforts to reduce...

Read Post
EPA Moves to Rescind Biden-Era Ethylene Oxide Limits, Reigniting Debate Over Safety and Supply Chain
Posted In: Federal Advocacy,
Date posted Mar 20

A new proposal from the U.S. Environmental Protection Agency (EPA) is reshaping the regulatory landscape for medical device sterilization -...

Read Post
FDA Guidance Links Study Design to 3-Year Exclusivity
Posted In: Federal Advocacy,
Date posted Mar 20

The FDA’s recent draft guidance clarifying the scope of 3-year New Clinical Investigation (NCI) exclusivity is more than a technical update...

Read Post
New Federal Legislation Targets "AI-ready" Biological Data to Accelerate Drug Development
Posted In: Federal Advocacy,
Date posted Mar 20

A bipartisan group of lawmakers has introduced new legislation aimed at tackling a foundational challenge in AI-driven drug discovery - the lack...

Read Post
House Biotech Caucus Endorses Key Biotechnology and Biomanufacturing Legislation
Posted In: Federal Advocacy,
Date posted Mar 6

The bipartisan House BIOtech Caucus recently announced its first-ever legislative endorsements, backing two bills aimed at strengthening U.S....

Read Post
MichBio Hosts Double-Header at the Capitol: Advancing Bioscience Policy and Partnerships
Posted In: State Advocacy,
Date posted Mar 6

MichBio welcomed Michigan legislators, staff, and industry leaders to Lansing last week for a pair of back-to-back events highlighting the...

Read Post